France · Source-listed medicine information
France / CIS 69985493
VINTENE, solution injectable pour perfusion
solution pour perfusion · intraveineuse
Source data retrieved: 2026-09-17. Clinical review is not yet available.
Product identity
At a glance
- Authorisation holder
- BAXTER
- Authorisation status
- Autorisation active
- Market status
- Commercialisée
- Country
- France
- Source reference
- CIS 69985493
Reported market status does not confirm current pharmacy stock.
From the official composition record
Ingredients & strength
Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.
| Ingredient | Strength / reference | Source role |
|---|---|---|
| ASPARTIQUE (ACIDE)solution | 0,3000 g100 ml | SAGroup 1 |
| CITRIQUE (ACIDE) ANHYDREsolution | 0,1000 g100 ml | SAGroup 2 |
| ALANINEsolution | 1,3000 g100 ml | SAGroup 3 |
| HISTIDINEsolution | 0,4000 g100 ml | SAGroup 4 |
| ISOLEUCINEsolution | 0,7000 g100 ml | SAGroup 5 |
| LEUCINEsolution | 1,4000 g100 ml | SAGroup 6 |
| LYSINEsolution | 1 g100 ml | SAGroup 7 |
| PHÉNYLALANINEsolution | 0,9000 g100 ml | SAGroup 8 |
| SÉRINEsolution | 0,3000 g100 ml | SAGroup 9 |
| THRÉONINEsolution | 0,5500 g100 ml | SAGroup 10 |
| TRYPTOPHANE Lsolution | 0,2500 g100 ml | SAGroup 11 |
| VALINEsolution | 0,7000 g100 ml | SAGroup 12 |
| GLYCINEsolution | 0,9200 g100 ml | SAGroup 13 |
| GLUTAMIQUE (ACIDE)solution | 0,5000 g100 ml | SAGroup 14 |
| ARGININEsolution | 1,5000 g100 ml | SAGroup 15 |
| CYSTÉINE (CHLORHYDRATE DE)solution | 0,2000 g100 ml | SAGroup 16 |
| MÉTHIONINEsolution | 0,7000 g100 ml | SAGroup 17 |
| MALIQUE (ACIDE)solution | 0,1200 g100 ml | SAGroup 18 |
| PROLINEsolution | 1,1000 g100 ml | SAGroup 19 |
| TYROSINEsolution | 0,0400 g100 ml | SAGroup 20 |
| ORNITHINEsolution | 0,1 g100 ml | FTGroup 23 |
| ACÉTIQUE (ACIDE)solution | 0,24 ml100 ml | SAGroup 21 |
| ORNITHINE (CHLORHYDRATE D')solution | 0,1275 g100 ml | SAGroup 23 |
Pack references
Presentations (3)
CIP13 3400932371518
Présentation active · Déclaration de commercialisationCIP13 3400957335007
Présentation active · Déclaration de commercialisationCIP13 3400957335175
Présentation active · Déclaration de commercialisationFrom the French medicines authority
Official documents
The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.
Open the official product entryBDPM · CIS 69985493 · Opens in a new tabCheck the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.
Where this information comes from
Sources & dates
Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.
| Source file | Retrieved | Source file modified |
|---|---|---|
| fr_products.txt | Not supplied | |
| fr_composition.txt | Not supplied | |
| fr_packs.txt | Not supplied |
Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.
Our sources and review process →